The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALLERGAN PLC | SHS | G0177J108 | 143,047 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 53,398 | 2,650,000 | SH | SOLE | 2,650,000 | 0 | 0 | ||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 63,051 | 1,616,690 | SH | SOLE | 1,616,690 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 141,017 | 515,000 | SH | SOLE | 515,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 79,063 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
BROOKDALE SENIOR LIVING | COM | 112463104 | 43,615 | 6,500,000 | SH | SOLE | 6,500,000 | 0 | 0 | ||
CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 27,113 | 1,236,360 | SH | SOLE | 1,236,360 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 43,560 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 9,560 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ENDO INTL PLC | SHS | G30401106 | 14,850 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
ENDOLOGIX INC | COM | 29266S106 | 39,339 | 9,300,000 | SH | SOLE | 9,300,000 | 0 | 0 | ||
ENVISION HEALTHCARE CORP | COM | 29414D100 | 109,526 | 2,850,000 | SH | SOLE | 2,850,000 | 0 | 0 | ||
GENOMIC HEALTH INC | COM | 37244C101 | 76,914 | 2,458,100 | SH | SOLE | 2,458,100 | 0 | 0 | ||
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 58,605 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 57,960 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
HCA HEALTHCARE INC | COM | 40412C101 | 121,250 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
K2M GROUP HLDGS INC | COM | 48273J107 | 25,570 | 1,349,323 | SH | SOLE | 1,349,323 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 65,880 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 2,456 | 135,300 | SH | SOLE | 135,300 | 0 | 0 | ||
MYLAN N V | SHS EURO | N59465109 | 51,463 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
MYRIAD GENETICS INC | COM | 62855J104 | 44,325 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 159,390 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
NUVASIVE INC | COM | 670704105 | 62,652 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
PERRIGO CO PLC | SHS | G97822103 | 33,336 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 9,178 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 164,329 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
SURGERY PARTNERS INC | COM | 86881A100 | 2,317 | 135,084 | SH | SOLE | 135,084 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 103,063 | 4,250,000 | SH | SOLE | 4,250,000 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 98,567 | 1,725,000 | SH | SOLE | 1,725,000 | 0 | 0 | ||
UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 92,360 | 780,000 | SH | SOLE | 780,000 | 0 | 0 | ||
VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 23,880 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 16,170 | 815,000 | SH | SOLE | 815,000 | 0 | 0 |